Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro antibacterial activity of amikacin and ticarcillin, alone and in combination, against Pseudomonas aerurginosa.

Literature DB >> 98109

In vitro antibacterial activity of amikacin and ticarcillin, alone and in combination, against Pseudomonas aerurginosa.

Abstract

In vitro antimicrobial susceptibility studies using amikacin and ticarcillin, alone and in combination, were performed on 20 strains of Pseudomonas aeruginosa. All strains were susceptible to amikacin, and ticarcillin was active against 16 of the 20 strains. Enhanced anti-pseudomonas activity could be demonstrated with the combination of amikacin and ticarcillin.

Entities: Chemical Species

Mesh：

Substances：

Year: 1978 PMID： 98109 PMCID： PMC352379 DOI： 10.1128/AAC.13.6.997

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

11 in total

1. Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.

Authors: W K Lau; L S Young; R E Black; D J Winston; S R Linne; R J Weinstein; W L Hewitt
Journal: Am J Med Date: 1977-06 Impact factor: 4.965

2. Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin.

Authors: J Klastersky; C Hensgens; L Debusscher
Journal: Antimicrob Agents Chemother Date: 1975-05 Impact factor: 5.191

3. Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.

Authors: W H Greene; M Moody; S Schimpff; V M Young; P H Wiernik
Journal: Ann Intern Med Date: 1973-11 Impact factor: 25.391

4. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.

Authors: S Schimpff; W Satterlee; V M Young; A Serpick
Journal: N Engl J Med Date: 1971-05-13 Impact factor: 91.245

5. Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.

Authors: H C Neu; G J Garvey
Journal: Antimicrob Agents Chemother Date: 1975-10 Impact factor: 5.191

6. Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment.

Authors: W Gaman; C Cates; C F Snelling; B Lank; A R Ronald
Journal: Antimicrob Agents Chemother Date: 1976-03 Impact factor: 5.191

7. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.

Authors: E R Wald; H C Standiford; B A Tatem; F M Calia; R B Hornick
Journal: Antimicrob Agents Chemother Date: 1975-03 Impact factor: 5.191

8. Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo.

Authors: K R Comber; M J Basker; C D Osborne; R Sutherland
Journal: Antimicrob Agents Chemother Date: 1977-06 Impact factor: 5.191

9. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.

Authors: R M Kluge; H C Standiford; B Tatem; V M Young; W H Greene; S C Schimpff; F M Calia; R B Hornick
Journal: Antimicrob Agents Chemother Date: 1974-10 Impact factor: 5.191

Review 4. An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.

Authors: Anand Kumar
Journal: Virulence Date: 2013-11-01 Impact factor: 5.882

4 in total